MIRELLA ZAFFUTO Curriculum Vitae Contact Information ... - SSFA
MIRELLA ZAFFUTO Curriculum Vitae Contact Information ... - SSFA
MIRELLA ZAFFUTO Curriculum Vitae Contact Information ... - SSFA
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>MIRELLA</strong> <strong>ZAFFUTO</strong><br />
<strong>Curriculum</strong> <strong>Vitae</strong><br />
<strong>Contact</strong> <strong>Information</strong><br />
Address: Via Manzoni, 20- 29100 Piacenza-Italy<br />
Telephone Number: +39.0523. 59.39.73<br />
Mobile:+39. 349. 54.28.633<br />
E-mail: mirella.zaffuto@zapharma.com; mirella.zaffuto@unife.it;<br />
Education<br />
Pavia Pavia University University, University Italy, Degree in Economics and Business, June 1988.<br />
Università Università Università Cattolica Cattolica del del Sacro Sacro Cuore Cuore of of of Cremona Cremona, Cremona Italy (1989-90), MBA-SMEA,<br />
Specialization and Master School in Economics of the Agricultural and Food System. SMEA<br />
is member of ASFOR, the Italian Association for Management Education Development.<br />
Università Università Università Cattolica Cattolica del del Sacro Sacro Cuore Cuore of of Piacenza Piacenza, Piacenza Italy (1995-98), Post-Graduate School of<br />
Business Administration and Management.<br />
Pavia Pavia Pavia University University, University School School School of of of Pharmacy Pharmacy, Pharmacy Italy (1999-2002), Post- Graduate Specialization in<br />
Regulatory Disciplines , Thesis Title: “ Planning and Conducting Pharmacoeconomics<br />
Analysis alongside a Randomized Clinical Trial”.<br />
Employment<br />
2002 2002-06, 2002 06, 2007 2007- 2007 present present Health Health Economist, Economist, Consultant<br />
Consultant<br />
Managing, conducting, preparing final reports, analyzing of published literature,<br />
interpreting and collaborating on economic, decision analytic, epidemiological or<br />
clinical-economic research as appropriate – prospectively (trials, registries) and<br />
retrospectively (database, chart review, expert, panel Delphi, other available data)<br />
including design of case report form, questionnaires, consent forms and other data<br />
collection tools , combining best available data in clinical-economic models,<br />
summarizing result and providing interpretation of findings;<br />
Managing the strategic identification of need and opportunities for Health Economics<br />
and Outcomes Research in order to demonstrate the drug value ( economic and<br />
humanistic benefits) in support of the brand value proposition, in support of pricing and<br />
reimbursement dossier for payer negotiations, and in support of the design of strategic<br />
post-market studies across a broad therapeutic range, including Hiv/AIDS, Parkinson<br />
Disease, Severe Chronic Pain, Radiotherapeutic Treatment, Myelodyspastic Syndrome,<br />
Osteoporosis, for a wide variety of clients;<br />
Designing and conducting studies to document the impact for in-line products and drug<br />
in development (phase IIb/IIIa/IIIb) relative to standard treatment on resource<br />
utilization, treatment costs, and productivity, applying appropriate methods,<br />
Burden/Cost of Illness studies, Development Forecast and ROI Models included and in<br />
support of BOA (Business Opportunity Assessment).<br />
MZ-CV_AUG-09
2006 2006-07 2006 07 07 CRA/Health CRA/Health Economics Economics Local Local Project Project Coordinator Coordinator in in Charles Charles River River Laboratories<br />
Laboratories<br />
and and Kendle/Milan.<br />
Kendle/Milan.<br />
Performing investigator recruitment, pre trial, site initiation, interim monitoring, and<br />
close-out visit in Phase II, Phase IIIA, Phase IIIB and Phase IV. In a variety of therapeutic<br />
areas including but not limited to:<br />
o HIV/AIDS<br />
o Restless Legs Syndrome<br />
o Chronic Idiopathic Thrombocytopenic<br />
o Osteoporosis<br />
Acting as the main line of communication between the sponsor and investigator.<br />
Verifying that investigator has adequate qualifications and resources and remain<br />
adequate throughout the trial period.<br />
Verifying, for the investigational product(s).<br />
Verifying that the investigator follows the approved protocol and all approved<br />
amendment(s), if any.<br />
Verifying that written Informed Consent was obtained before each subject’s<br />
participation in the trial.<br />
Ensuring that the investigator receives the current Investigator’s Brochure, all<br />
documents, and all trial supplies needed to conduct the trial properly and to comply<br />
with the applicable regulatory requirement(s).<br />
Ensuring that the investigator and the investigator’s trial staff are adequately informed<br />
about the trial.<br />
Verifying that the investigator and the investigator’s trial staff are performing the<br />
specified trial functions, in accordance with the protocol and any other written<br />
agreement between the sponsor and the investigator/institution, and have not<br />
delegated these functions to unauthorized individuals.<br />
Verifying that the investigator is enrolling only eligible subjects.<br />
Reporting the subject recruitment rate.<br />
Verifying that source documents and other trial records are accurate, complete, kept<br />
up-to-date and maintained.<br />
Communicating deviations from the protocol, SOPs, GCP, and the applicable regulatory<br />
requirements to the investigator and taking appropriate action designed to prevent<br />
recurrence of the detected deviation.<br />
Determining whether all adverse events (AEs) are appropriately reported within the<br />
time periods required by GCP, the protocol, The Ethical Committees, the sponsor, and<br />
the applicable regulatory requirement(s).<br />
Checking the accurancy and completeness of the case report forms (CRF) entries,<br />
source documents and other trial-related records against each other.<br />
Informing the investigator of any CRF entry error, omission, or illegibility.<br />
Taking part in Investigator Trials Meeting and Kick-off International Meeting<br />
2001 2001-02 2001 02 Contract Contract CRA CRA Administrative/Clinical Administrative/Clinical Contract Contract Specialist Specialist in in Parexel/Milan<br />
Parexel/Milan<br />
Responsible for Legal, Regulatory ,Economic contractual issues and negotiations with<br />
the legal/administrative departments of Hospitals and Universities in order to finalize<br />
Clinical Trial Agreement between sponsors and clinical research local sites.<br />
As the clinical contract specialist liaising with other departments, primarily Clinical and<br />
Regulatory Services and Project Management, on requirements for confidentially and<br />
clinical study agreement, reviewed site contract template to ensure legal compliance<br />
consistent practices, completeness and accuracy. Developing local Parexel template<br />
and adapting statements of agreement templates, as necessary. Negotiating and<br />
monitoring compliance with, new and amended contracts.<br />
1989 1989-2000<br />
1989 1989 2000 2000 Economist Economist , , , Free Free -lance lance<br />
MZ-CV_AUG-09